Wie geht’s weiter nach der Entzugsbehandlung?
Eine randomisiert-kontrollierte Pilotstudie zur integrierten ambulanten Psychotherapie bei alkoholabhängigen Patient_innen mit Doppeldiagnosen
Abstract
Zusammenfassung.Theoretischer Hintergrund: Bisher existieren keine systematischen ambulanten Angebote für Alkoholpatient_innen mit Doppeldiagnosen, die direkt nach Qualifizierter Entzugsbehandlung (QE) einsetzen. Fragestellung: Diese Pilotstudie untersucht, ob durch nahtlos beginnende integrierte ambulante Psychotherapie Alkoholtrinktage und komorbide psychopathologische Symptomatik bei Alkoholpatient_innen mit Doppeldiagnosen reduziert werden können. Methode: 30 alkoholabhängige Patient_innen mit Doppeldiagnose (F3 oder F4) wurden vor Entlassung aus der QE randomisiert (T1) in Experimentalgruppe (n = 15, nahtlos nach Entzugsbehandlung beginnende integrierte ambulante Psychotherapie) oder Kontrollgruppe (n = 15, Warte-Kontrollgruppe). Drei Monate nach QE (T2) wurden alle Patient_innen hinsichtlich Alkoholtrinktage (Timeline Followback, TLFB) und komorbider Symptomatik (Brief Symptom Inventory, BSI; Beck Depression Inventory, BDI) nachuntersucht. Resultate: Im Gruppenvergleich reduzierten sich die Trinktage von T1 zu T2 in der Experimentalgruppe signifikant stärker (92 % vs. 35 %). Psychische Belastung und Depressivität reduzierten sich deutlicher in der Experimentalgruppe. Schlussfolgerung: Integrierte Therapieformen sollten weiterentwickelt und evaluiert werden, um die ambulant-psychotherapeutische Versorgung dieser Patient_innengruppe zu verbessern.
Abstract.Background: Integrated outpatient treatment approaches after withdrawal treatment for alcoholics with comorbid disorders are lacking. Aim: This pilot study investigated whether alcohol drinking days and comorbid symptom severity can be reduced in patients with alcohol dependence and comorbid psychological disorders by integrated outpatient psychotherapy beginning after withdrawal treatment. Method: In all, 30 alcoholics with comorbidities (F3 or F4) were randomized before release from the withdrawal treatment (T1) to an experimental condition (n = 15, integrated outpatient psychotherapy starting immediately after withdrawal treatment) or a control condition (n = 15, waiting list). Alcohol drinking days (Timeline Followback, TLFB) and comorbid symptom severity (Brief Symptom Inventory, BSI; Beck Depression Inventory, BDI) were reassessed 3 months after release from the withdrawal treatment (T2). Results: There was a greater reduction in drinking days in the experimental condition (92 % vs. 35 %). There was also a greater decrease in general symptom severity and depression in the experimental condition. Conclusion: Further development and evaluation of integrated treatment approaches are needed to improve outpatient psychotherapeutic treatment and care for this group of patients.
Literatur
2015). S3-Leitlinie: Screening, Diagnose und Behandlung von alkoholbezogenen Störungen. Zugriff am 26. 07. 2018. Verfügbar unter https://www.awmf.org/leitlinien/detail/ll/076-001.html
(2014). Ambulante Psychotherapie der Substanzstörungen. Psychotherapeut, 59, 310 – 316.
(2009). Predicting post-treatment-initiation alcohol use among patients with severe mental illness and alcohol use disorders. Journal of Consulting and Clinical Psychology, 77, 1147 – 1158.
(2006). Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders. Journal of Psychoactive Drugs, 38, 449 – 460.
(2018). „Ein Jahr nach der Reform der Psychotherapie-Richtlinie – Wartezeiten 2018“. Zugriff am 18. 07. 2018. Verfügbar unter www.bptk.de
(2010). Do PTSD symptoms and course predict continued substance use for homeless individuals in contingency management for cocaine dependence? Behaviour Research and Therapy, 48, 588 – 598.
(1993). Personality disorders in alcoholics and drug addicts. Comprehensive Psychiatry, 34 (2), 87 – 94.
(2004). Qualifizierte Entzugsbehandlung bei Alkoholabhängigkeit. Psychoneuro, 30 (01), 37 – 41.
(2001). The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol and Alcoholism, 36, 249 – 255.
(2008). Treatment response of bipolar and unipolar alcoholics to an inpatient dual diagnosis program. Journal of Affective Disorders, 106, 265 – 272.
(2000). BSI. Brief Symptom Inventory – Deutsche Version. Manual. Göttingen: Beltz.
(2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders – Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61, 807 – 816.
(2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States – Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64, 830 – 842.
(2009). Beck Depressions-Inventar (BDI II). Frankfurt am Main: Pearson Assessment.
(2017). Wirksamkeit ambulanter Verhaltenstherapie bei Substanzstörungen und abhängigen Verhaltensweisen – Evaluation einer Spezialambulanz. Verhaltenstherapie, 27 (1), 7 – 14.
(2010). Exposure therapy for posttraumatic stress disorder in a residential substance use treatment facility. Professional Psychology: Research and Practice, 41 (1), 34 – 40.
(2009). Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry, 9 (1), 6.
(2015). Treatment outcome in substance use disorder patients with and without comorbid posttraumatic stress disorder: A systematic review. Psychotherapy Research, 25, 565 – 582.
(2011). Vorschläge zur Evaluation regulärer Psychotherapien an Hochschulambulanzen im Sinne der Phase-IV-Therapieforschung. Zeitschrift für Klinische Psychologie und Psychotherapie, 40, 22 – 32.
(2006). Co-occurring disorders: Policy and practice in Germany. American Journal on Addictions, 15, 261 – 267.
(2009). Urinary ethyl glucuronide (EtG) and ethyl sulphate (EtS) assessment: Valuable tools to improve verification of abstention in alcohol-dependent patients during in-patient treatment and at follow-ups. Addiction, 104, 921 – 926.
(2007). Evidenzbasierte Behandlung der Alkoholabhängigkeit. Der Nervenarzt, 78, 1321 – 1331.
(2000). The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clinical Psychology Review, 20, 149 – 171.
(2002). Impact of alcohol detoxification on anxiety and depressive symptoms. Drug & Alcohol Dependence, 68, 215 – 220.
(2018).
(Therapie der Alkoholabhängigkeit . In M. von HeydeH. JungaberleT. Majić (Hrsg.), Handbuch Psychoaktive Substanzen (S. 497 – 514). Berlin, Heidelberg: Springer.2009). Behandlungserfolg nach qualifiziertem Alkoholentzug. Der Nervenarzt, 80, 1085 – 1092.
(2004). Psychische Störungen und Sucht: Doppeldiagnosen. Göttingen: Hogrefe.
(2003). The external validity of controlled clinical trials of psychotherapy for depression and anxiety: A naturalistic study. Psychology and Psychotherapy: Theory, Research and Practice, 76 (2), 109 – 132.
(2012). Reducing dropout among traumatized alcohol patients in detoxification treatment: A pilot intervention study. European Addiction Research, 18 (2), 54 – 63.
(2013). Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012. SUCHT – Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice, 59, 321 – 331.
(2016). Der Epidemiologische Suchtsurvey 2015. Sucht, 62, 259 – 269.
(2016). Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use. Substance Abuse, 37, 209 – 214.
(2012). Trauma und Sucht: Implikationen für die Psychotherapie. Sucht, 58, 227 – 235.
(1963). The effect of experimenter bias on the performance of the albino rat. Systems Research and Behavioral Science, 8, 183 – 189.
(2010). CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine, 8 (1), 18.
(2013). Integrated psychosocial treatment programme for substance abusers: relapse prevention and social anxiety diminution: A systematic review of published literature. Journal of Addiction Research and Therapy, 7, 2.
(1992).
(Timeline Follow-back: A technique for assessing self-reported ethanol consumption . In J. AllenR. Z. Litten (Eds.), Measuring alcohol consumption psychosocial and biological methods (pp. 41 – 72). Totowa, NJ: Humana Press.1997). Zum Krankheitsverlauf Alkoholabhängiger nach einer stationären Entgiftungs- und Motivationsbehandlung. Der Nervenarzt, 68, 574 – 581.
(1999). Substance dependence and personality disorders: Comorbidity and treatment outcome in an inpatient treatment population. Journal of Studies on Alcohol, 60, 271 – 277.
(1995). Prevalence of personality disorders among alcoholics and drug addicts: An overview. European Addiction Research, 1, 166 – 177.
(1998). Personality disorders predict relapse in alcoholic patients. Addictive Behaviors, 23, 869 – 882.
(2004). The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychological Bulletin, 130, 631.
(1997). Strukturiertes Klinisches Interview für DSM-IV. Achse I und Achse II. Göttingen: Hogrefe.
(